Review Article

Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis

Table 1

Basic characteristics of the included studies in the meta-analysis.

First author’s name, year [reference]DesignNumber of patientsRegionPopulation typeMean age (years)Women (%)Ethnicity (%)NGAL assayPathological classification criteriaQUADAS-2 score

Brunner, 2006 [20]CS35USAChildren11.6 (4)a32 (91)ELISA (Denmark)dWHO16
Pitashny, 2007 [21]CS70USAAdults35 (28-44)a58 (83)African American (41), Hispanic (56), others (3)ELISA (Denmark)dWHO15
Hinze, 2009 [22]PC111USAChildrenb89 (90)White (49.5), African American (32.4), Asian (12.6), Hispanic (11.7)ELISA (Denmark)dWHO14
Rubinstein, 2010 [23]PC107USA (Bronx)Adults41 (12)a97 (91)Hispanic (47), Black (46), White (2), others (4)ELISA (Denmark)dWHO12
Rubinstein, 2010 [23]PC35UK (London)Adults41 (13)a34 (97)White (49), Black (23), Asian (14), Southeast Asian (9), others (6)ELISA (Denmark)dWHO12
Kiani, 2012 [24]PC107USAAdults41c97 (91)Black (51), White (36), Asian (4), Hispanic (4), others (5)ELISA (R&D)eISN/RPS13
Alharazy, 2013 [25]CS100MalaysiaAdultsb92 (92)Malay (41), Chinese (55), Indian (4)ELISA (R&D)eWHO12
Hammad, 2013 [26]CS33EgyptChildren10 (8-12)a25 (76)ELISA (R&D)eISN/RPS15
Sharifipour, 2013 [27]CS52IranAdultsb44 (85)ELISA (R&D)eWHO12
Torres-Salido, 2014 [29]CS123SpainAdults33 (27-42)a109 (89)White (93), Hispanic (2), African American (2), others (2)ELISA (Denmark)dISN/RPS13
Torres-Salido, 2014 [29]PC45SpainAdults31 (23-41)a39 (87)White (89), Hispanic (7), African American (2), others (2)ELISA (Denmark)dISN/RPS13
Watson, 2014 [30]PC64UKChildren11.3 (8.0-13.3)a51 (80)Caucasian (50), Black African (14), Indian (9), Caribbean (8), Asian (6), Bangladeshi (4), mixed race (3), Chinese (2), others (2)Architect assayf14
Maeda-Hori, 2014 [28]PC64JapanAdultsb46 (72)Asian (100)ELISA (R&D)eISN/RPS16
Elewa, 2015 [31]PC30EgyptAdultsb29 (97)ELISA (Boster)g15
Susianti, 2015 [32]CS50IndonesiaAdultsb48 (96)Javanese (92), Madurese (8)ELISA (RayBiotech)hISN/RPS10
Tawfik, 2015 [33]CS35EgyptAdults30 (24-37)a31 (89)ELISA (R&D)eWHO13
Youssef, 2015 [34]CS44EgyptAdultsb35 (80)ELISAi11
Satirapoj, 2017 [35]PC68UKAdultsb66 (97)ELISA (R&D)eISN/RPS14
El Shahawy, 2018 [36]PC70EgyptAdultsb67 (96)ELISA (R&D)eISN/RPS10
Gómez-Puerta, 2018 [37]CS120ColombiaAdultsb105 (88)Mestizo (76.7), Afro Latin-American (21.6), Caucasian (1), Colombian Amerindian (1)ELISA (R&D)eWHO10
Li, 2019 [38]PC90China
Taiwan
Adultsb75 (83)ELISA (R&D)jWHO15

NGAL: neutrophil gelatinase-associated lipocalin; CS: cross-sectional study; PC: prospective cohort study; USA: the United States of America; UK: the United Kingdom; ELISA: enzyme-linked immunosorbent assay; WHO: World Health Organization classification system; ISN/RPS: the International Society of Nephrology/Renal Pathology Society classification system. QUADAS-2: quality assessment tool for diagnostic accuracy studies 2; “yes” or “low concern”: 1 score; “no” or “high concern” or “unclear”: 0 score. aMedian (interquartile range (IQR)). b. cMedian. (Denmark)d: Bioporto, Gentofte, Denmark. (R&D)e: R&D Systems, Minneapolis, MN, USA. Architect assayf: Abbott Laboratories, Abbott Park, IL, USA. (Boster)g: Boster Biological Technology Co., Ltd. (RayBiotech)h: ELHLipocalin2-001, RayBiotech® Inc., Norcross, GA, USA. ELISAi: BioVendor, Asheville, NC28806, USA; (R&D)j: Quantikine: R&D Systems, Inc.